Literature DB >> 21778429

Aortic aneurysm generation in mice with targeted deletion of integrin-linked kinase in vascular smooth muscle cells.

Dongxiao Shen1, Jian Li, John J Lepore, Thomas J T Anderson, Sumita Sinha, Alexander Y Lin, Lan Cheng, Ethan David Cohen, Jesse D Roberts, Shoukat Dedhar, Michael S Parmacek, Robert E Gerszten.   

Abstract

RATIONALE: Integrin-linked kinase (ILK) is located at focal adhesions and links the extracellular matrix (ECM) to the actin cytoskeleton via β1- and β3-integrins. ILK plays a role in the activation of kinases including protein kinase B/Akt and glycogen synthase kinase 3β and regulates cell proliferation, motility, and survival.
OBJECTIVE: To determine the function of ILK in vascular smooth muscle cells (SMCs) in vivo. METHODS AND
RESULTS: SM22Cre(+)Ilk(Fl/Fl) conditional mutant mice were generated in which the Ilk gene was selectively ablated in SMCs. SM22Cre(+)Ilk(Fl/Fl) conditional mutant mice survive to birth but die in the perinatal period exhibiting multiple vascular pathologies including aneurysmal dilatation of the aorta and patent ductus arteriosus (PDA). Defects in morphogenetic development of the aorta were observed as early as E12.5 in SM22Cre(+)Ilk(Fl/Fl) mutant embryos. By late gestation (E16.5 to 18.5), striking expansion of the thoracic aorta was observed in ILK mutant embryos. Histological analyses revealed that the structural organization of the arterial tunica media is severely disrupted with profound derangements in SMC morphology, cell-cell, and cell-matrix relationships, including disruption of the elastic lamellae. ILK deletion in primary aortic SMCs results in alterations of RhoA/cytoskeletal signaling transduced through aberrant localization of myocardin-related transcription factor (MRTF)-A repressing the transcription and expression of SMC genes, which are required for the maintenance of the contractile SMC phenotype.
CONCLUSIONS: These data identify a molecular pathway linking ILK signaling to the contractile SMC gene program. Activation of this pathway is required for morphogenetic development of the aorta and ductus arteriosus during embryonic and postnatal survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21778429      PMCID: PMC3351207          DOI: 10.1161/CIRCRESAHA.110.239343

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  48 in total

1.  A critical role for elastin signaling in vascular morphogenesis and disease.

Authors:  Satyajit K Karnik; Benjamin S Brooke; Antonio Bayes-Genis; Lise Sorensen; Joshua D Wythe; Robert S Schwartz; Mark T Keating; Dean Y Li
Journal:  Development       Date:  2003-01       Impact factor: 6.868

2.  Ca2+-independent smooth muscle contraction. a novel function for integrin-linked kinase.

Authors:  J T Deng; J E Van Lierop; C Sutherland; M P Walsh
Journal:  J Biol Chem       Date:  2001-02-08       Impact factor: 5.157

Review 3.  Integrins: bidirectional, allosteric signaling machines.

Authors:  Richard O Hynes
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

4.  Isolation of vascular smooth muscle cells from a single murine aorta.

Authors:  J L Ray; R Leach; J M Herbert; M Benson
Journal:  Methods Cell Sci       Date:  2001

5.  PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways.

Authors:  P Komalavilas; S Mehta; C J Wingard; D T Dransfield; J Bhalla; J E Woodrum; J R Molinaro; C M Brophy
Journal:  J Appl Physiol (1985)       Date:  2001-10

6.  C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes.

Authors:  A Craig Mackinnon; Hiroshi Qadota; Kenneth R Norman; Donald G Moerman; Benjamin D Williams
Journal:  Curr Biol       Date:  2002-05-14       Impact factor: 10.834

7.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.

Authors:  Enid R Neptune; Pamela A Frischmeyer; Dan E Arking; Loretha Myers; Tracie E Bunton; Barbara Gayraud; Francesco Ramirez; Lynn Y Sakai; Harry C Dietz
Journal:  Nat Genet       Date:  2003-02-24       Impact factor: 38.330

8.  Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization.

Authors:  C P Mack; A V Somlyo; M Hautmann; A P Somlyo; G K Owens
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

9.  Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation.

Authors:  Kevin L Du; Hon S Ip; Jian Li; Mary Chen; Frederic Dandre; William Yu; Min Min Lu; Gary K Owens; Michael S Parmacek
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

10.  Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion.

Authors:  S N Nikolopoulos; C E Turner
Journal:  J Cell Biol       Date:  2000-12-25       Impact factor: 10.539

View more
  20 in total

1.  β1-integrin is essential for vasoregulation and smooth muscle survival in vivo.

Authors:  Kirsten A Turlo; Jason Scapa; Pooneh Bagher; Allan W Jones; Robert Feil; Ronald J Korthuis; Steven S Segal; M Luisa Iruela-Arispe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-25       Impact factor: 8.311

Review 2.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

Review 3.  Elastic fibers and biomechanics of the aorta: Insights from mouse studies.

Authors:  Hiromi Yanagisawa; Jessica Wagenseil
Journal:  Matrix Biol       Date:  2019-03-15       Impact factor: 11.583

Review 4.  Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections.

Authors:  Jay D Humphrey; Martin A Schwartz; George Tellides; Dianna M Milewicz
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

Review 5.  Integrin signaling in vascular function.

Authors:  Nikolay L Malinin; Elzbieta Pluskota; Tatiana V Byzova
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

6.  Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells.

Authors:  Shao-Qing Kuang; Callie S Kwartler; Katerina L Byanova; John Pham; Limin Gong; Siddharth K Prakash; Jian Huang; Kristine E Kamm; James T Stull; H Lee Sweeney; Dianna M Milewicz
Journal:  Circ Res       Date:  2012-04-17       Impact factor: 17.367

7.  Smooth muscle hyperplasia due to loss of smooth muscle α-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-β.

Authors:  Christina L Papke; Jiumei Cao; Callie S Kwartler; Carlos Villamizar; Katerina L Byanova; Soon-Mi Lim; Harini Sreenivasappa; Grant Fischer; John Pham; Meredith Rees; Miranda Wang; Christine Chaponnier; Giulio Gabbiani; Aarif Y Khakoo; Joya Chandra; Andreea Trache; Warren Zimmer; Dianna M Milewicz
Journal:  Hum Mol Genet       Date:  2013-04-15       Impact factor: 6.150

8.  Effects of Advancing Gestation and Non-Caucasian Race on Ductus Arteriosus Gene Expression.

Authors:  Nahid Waleh; Anne Marie Barrette; John M Dagle; Allison Momany; Chengshi Jin; Nancy K Hills; Elaine L Shelton; Jeff Reese; Ronald I Clyman
Journal:  J Pediatr       Date:  2015-08-08       Impact factor: 4.406

9.  Recombinant Osteopontin Stabilizes Smooth Muscle Cell Phenotype via Integrin Receptor/Integrin-Linked Kinase/Rac-1 Pathway After Subarachnoid Hemorrhage in Rats.

Authors:  Jiang Wu; Yang Zhang; Peng Yang; Budbazar Enkhjargal; Anatol Manaenko; Jiping Tang; William J Pearce; Richard Hartman; Andre Obenaus; Gang Chen; John H Zhang
Journal:  Stroke       Date:  2016-03-22       Impact factor: 7.914

10.  PTBP1 Targets ILK to Regulate the Hypoxia-Induced Phenotypic Transformation of Pulmonary Artery Smooth Muscle Cells.

Authors:  Gaoliang Yan; Renhua Sun; Zhongpu Chen; Xiaodong Pan; Zulong Sheng; Chengchun Tang
Journal:  Drug Des Devel Ther       Date:  2021-05-13       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.